1. Signaling Pathways
  2. Protein Tyrosine Kinase/RTK
  3. Bcr-Abl
  4. Bcr-Abl Control

Bcr-Abl Control

Bcr-Abl Control (1):

Cat. No. Product Name Effect Purity
  • HY-41940
    Dasatinib intermediate-1
    Control
    Dasatinib intermediate-1 is an intermediate in the synthesis of Dasatinib (HY-10181). Dasatinib Is a highly potent, ATP competitive, orally active dual Src/Bcr-Abl inhibitor with potent antitumor activity.